%0 Journal Article
%T Prognostic Factors in Cardiorenal Syndrome Type 1: Retrospective Observational and Analytical Study
%A Mariam El Galiou
%A Amal Zniber
%A Hajar Fitah
%A Naima Ouzeddoun
%A Tarik Bouattar
%A Nawal Doghmi
%A Laila Lahlou
%A Loubna Benamar
%J World Journal of Cardiovascular Diseases
%P 435-445
%@ 2164-5337
%D 2024
%I Scientific Research Publishing
%R 10.4236/wjcd.2024.147037
%X <b>Introduction:</b> Type 1 cardiorenal syndrome (CRS 1) is characterized by acute impairment of cardiac function leading to acute renal dysfunction. CRS1 is present in 25% of patients admitted for heart failure. The objective of our study is to analyze the epidemiological, clinical, therapeutic profile and the risk and prognostic factors of these patients. <b>Materials</b> <b>and</b> <b>Methods:</b> We identified 120 patients with cardiorenal syndrome (CRS) over a one-year period to determine the prevalence and risk factors for developing CRS 1. We analyzed the clinical, biological, and evolutionary profiles of patients with CRS 1 and determined the risk factors for the occurrence of acute kidney injury (AKI) as well as the mortality factors in these patients. <b>R&#233;sultats</b><b>:</b> The average age of our patients with CRS1 is 58 &#177; 9 years, with a sex ratio of 1.4. The average eGFR of our patients is 35 &#177; 6.5 ml/min/1.73m<sup>2</sup>. Diabetes was found in 17% of our patients and hypertension in 14%. The etiology of cardiac impairment is predominantly acute coronary syndrome (ACS), followed by rhythm disorders. Renally, all our patients have acute kidney injury (AKI), with 86% having functional acute renal failure and 14% having acute tubular necrosis. Therapeutically, 50% of our patients are on diuretics, 42% receive beta-blocker treatment, and RAAS blockers are used in 29% of cases. Renal replacement therapy (RRT) sessions were required in 13.8% of cases. In univariate analysis, male gender, tachyarrhythmia, and hypertension are associated with the early onset of acute kidney injury (AKI). The use of diuretics, anemia, and low left ventricular ejection fraction (LVEF) are linked to a higher risk of developing CRS 1 (p = 0.021, p = 0.037, p = 0.010 respectively). In multivariate analysis, advanced age is significantly associated with increased mortality risk in CRS 1 patients (p = 0.030), while beta-blocker use is considered a protective factor (p = 0.014). <b>Conclusion:</b> Our study identifies several key factors associated with outcomes in type 1 CRS. Male gender, tachyarrhythmia, and hypertension are linked to early-onset AKI. The use of diuretics and the presence of anemia increase the risk of developing CRS1. Advanced age is significantly associated with higher mortality rates. Conversely, the use of beta-blockers appears to be protective in this patient population.
%K Acute Kidney Injury
%K Type 1 Cardiorenal Syndrome
%K Acute Heart Failure
%K Diuretics
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=134767